Abstract
Background & aims
Irritable bowel syndrome (IBS) is a functional disorder with an etiology that has been linked to both psychological stress and infection. The primary aim of this study was to examine the hypothalamic-pituitary-adrenal axis in patients with IBS and to relate such response to plasma cytokine profiles.Methods
A total of 151 subjects, 76 patients and 75 controls, were recruited. The patients with IBS were diagnosed according to Rome II criteria. Forty-nine patients and 48 matched controls had cytokine levels measured, and a subset of 21 patients and 21 controls also underwent a corticotropin-releasing hormone (CRH) stimulation test with plasma levels of adrenocorticotropic hormone (ACTH) and cortisol measured. The remaining 27 patients and 27 controls underwent a dexamethasone (1 mg) challenge.Results
Cortisol and the proinflammatory cytokines interleukin (IL)-6 (together with its soluble receptor) and IL-8 were elevated in all IBS subgroups (diarrhea predominant, constipated, and alternators), although the elevation was most marked in the constipated subgroup. There was no alteration in the anti-inflammatory cytokine IL-10. Following CRH infusion, an exaggerated release of both ACTH and cortisol was observed in patients with IBS. There was a significant correlation between the ACTH response (deltaACTH) and the IL-6 levels. A similar relationship existed between the deltaACTH/deltacortisol ratio and the IL-6 levels. Dexamethasone suppression of cortisol was similar in patients and controls.Conclusions
IBS is characterized by an overactivation of the hypothalamic-pituitary-adrenal axis and a proinflammatory cytokine increase.Full text links
Read article at publisher's site: https://doi.org/10.1053/j.gastro.2005.11.033
Read article for free, from open access legal sources, via Unpaywall: http://www.gastrojournal.org/article/S0016508505023942/pdf
References
Articles referenced by this article (50)
An evidence-based approach to the management of irritable bowel syndrome in North America
Am J Gastroenterol, (Suppl):S1- 2002
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral.
Gut, (1):78-82 2000
MED: 10601059
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.
Aliment Pharmacol Ther, (5):643-650 2003
MED: 12641512
Current concepts of the irritable bowel syndrome
Scand J Gastroenterol, (Suppl 237) 2003
Evolving pathophysiologic models of functional gastrointestinal disorders.
Gastroenterology, (7):2032-2048 2002
MED: 12055608
Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.
Gut, (6):804-811 2000
MED: 11076879
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.
Gastroenterology, (6):1651-1659 2003
MED: 14724817
The infectious intestinal disease study of England: a prospective evaluation of symptoms and health care use after an acute episode.
Epidemiol Infect, (3):453-460 2003
MED: 12825729
Show 10 more references (10 of 50)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1053/j.gastro.2005.11.033
Article citations
Morphological Changes of the Pituitary Gland in Patients with Irritable Bowel Syndrome Using Magnetic Resonance Imaging.
J Imaging, 10(9):226, 13 Sep 2024
Cited by: 0 articles | PMID: 39330446 | PMCID: PMC11433444
A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome.
BMC Gastroenterol, 24(1):217, 05 Jul 2024
Cited by: 0 articles | PMID: 38970007 | PMCID: PMC11225114
Review Free full text in Europe PMC
Major depressive disorder and the risk of irritable bowel syndrome: A Mendelian randomization study.
Mol Genet Genomic Med, 12(3):e2413, 01 Mar 2024
Cited by: 1 article | PMID: 38439604
Butterflies in the gut: the interplay between intestinal microbiota and stress.
J Biomed Sci, 30(1):92, 28 Nov 2023
Cited by: 2 articles | PMID: 38012609 | PMCID: PMC10683179
Review Free full text in Europe PMC
Non-invasive neuromodulation: an emerging intervention for visceral pain in gastrointestinal disorders.
Bioelectron Med, 9(1):27, 22 Nov 2023
Cited by: 4 articles | PMID: 37990288 | PMCID: PMC10664460
Review Free full text in Europe PMC
Go to all (369) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors.
Am J Gastroenterol, 103(10):2570-2576, 10 Sep 2008
Cited by: 88 articles | PMID: 18785949
Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
Arthritis Rheum, 43(4):872-880, 01 Apr 2000
Cited by: 112 articles | PMID: 10765933
Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
Psychoneuroendocrinology, 30(2):188-198, 01 Feb 2005
Cited by: 81 articles | PMID: 15471616
Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
J Gastroenterol, 42 Suppl 17:48-51, 01 Jan 2007
Cited by: 85 articles | PMID: 17238026
Review